---
schema_version: "secwatch.filing_event.v1"
accession: "0001837607-25-000072"
form_type: "8-K"
ticker: "AEON"
cik: "0001837607"
company_name: "AEON Biopharma, Inc."
filed_at: "2025-11-13T23:59:59+00:00"
generated_at: "2026-05-16T20:34:51.189101+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# AEON Biopharma raises $6M private placement, plans Daewoong note exchange for ~23M shares

## Summary
- First closing of private placement expected week of Nov 17, 2025: 1,964,905 shares/pre-funded warrants at $0.9116 per share.
- Second closing subject to stockholder approval: 4,616,924 shares and 6,581,829 warrants at $1.09392.
- Term sheet with Daewoong to exchange existing notes for $1.5M new note, ~23.1M shares, and 8M warrants.
- True-Up Warrants issued to maintain investor ownership percentage post-Daewoong exchange.
- Investors receive registration rights for resale of shares and warrant shares.

## SEC filing metadata
- accession: 0001837607-25-000072
- form_type: 8-K
- ticker: AEON
- cik: 0001837607
- company_name: AEON Biopharma, Inc.
- filed_at: 2025-11-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1837607/000183760725000072/0001837607-25-000072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1837607/000183760725000072/aeon-20251112x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001837607-25-000072
- JSON: https://secwatch.observer/filing/0001837607-25-000072.json
- Plain text: https://secwatch.observer/filing/0001837607-25-000072.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.